High intake of the artificial sweetener sucralose may reduce the efficacy of ICIs in patients with cancer, data suggest.

Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured.

Stereotactic ablative body radiation therapy (SABR) is actively being explored for patients with renal cell carcinoma (RCC).

Research links environmental exposures to CKD development and progression. Here’s what clinicians and patients need to know.

Research teams investigated the association between hemoglobin levels and cognitive impairment in patients with chronic kidney disease (CKD) or end-stage (ESKD).

The FDA has approved an expanded indication of the IV formulation of Avtozma to include the treatment of CRS in patients 2 years of age and older.

(HealthDay News) — In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August data brief published by the ...

Improved maximum urinary flow rate and lower International Prostate Symptom Scores seen for adherent versus nonadherent patients.

The Food and Drug Administration (FDA) has approved the first generic version of Venofer ® (iron sucrose) Injection.

(HealthDay News) — Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or obesity, according to a study ...

Patients who regularly use antiemetic medication, such as for nausea from chemotherapy, appear at increased risk for chronic kidney disease. Patients who use antiemetics have an increased risk of ...

There is decreased risk for MACE and all-cause mortality in dialysis-dependent patients with ASCVD who are treated with statins.